Skip to content

Myriad Genetics MYGN Earnings yield

Earnings yield at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
4.3%+0.5pp
Quest Diagnostics logo
Quest DiagnosticsDGX
4.8%0.0pp
NeoGenomics logo
NeoGenomicsNEO
-10.3%+16.7pp
Veracyte logo
VeracyteVCYT
3.4%+2.0pp
Guardant Health logo
Guardant HealthGH
-3.6%-1.3pp
Natera, Inc. logo
Natera, Inc.NTRA
-1.4%0.0pp

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

Based on trailing twelve months.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's earnings yield?
Myriad Genetics (MYGN) reported earnings yield of -95% in Q1 2026.
How has Myriad Genetics's earnings yield changed year-over-year?
Myriad Genetics's earnings yield decreased by 659.1% year-over-year, from -12.5% to -95%.
What is the long-term trend for Myriad Genetics's earnings yield?
Over 5 years (2020 to 2025), Myriad Genetics's earnings yield has grown at a 38.3% compound annual growth rate (CAGR), from -12.6% to -63.8%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.